vs
艾地盟（ADM）与达维塔（DVA）财务数据对比。点击上方公司名可切换其他公司
艾地盟的季度营收约是达维塔的1.7倍（$6.1B vs $3.6B），艾地盟净利率更高（7.5% vs 6.5%，领先1.1%），艾地盟同比增速更快（123.5% vs 12.3%），过去两年达维塔的营收复合增速更高（6.6% vs -47.4%）
艾地盟（ADM）是美国跨国食品加工与大宗商品贸易企业，1902年成立，总部位于伊利诺伊州芝加哥。集团在全球布局270多家加工厂及420多个农作物采购站点，将谷物、油籽加工为食品、饮料、营养保健、工业生产及动物饲料领域的各类产品，供应全球市场。
达维塔是美国肾脏透析服务提供商，在美国运营2675家门诊中心，服务20.08万名患者；同时在其他11个国家布局367家门诊中心，服务4.94万名患者。公司主要服务终末期肾病患者，这类患者除非接受捐肾移植，否则通常需要终生每周接受三次透析治疗。
ADM vs DVA — 直观对比
营收规模更大
ADM
是对方的1.7倍
$3.6B
营收增速更快
ADM
高出111.3%
12.3%
净利率更高
ADM
高出1.1%
6.5%
两年增速更快
DVA
近两年复合增速
-47.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $6.1B | $3.6B |
| 净利润 | $456.0M | $234.2M |
| 毛利率 | 20.0% | — |
| 营业利润率 | 7.9% | 15.5% |
| 净利率 | 7.5% | 6.5% |
| 营收同比 | 123.5% | 12.3% |
| 净利润同比 | -19.6% | 43.8% |
| 每股收益（稀释后） | $0.95 | $3.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADMDVA
| Q1 26 | — | $3.6B | ||
| Q4 25 | $6.1B | $3.6B | ||
| Q3 25 | $6.4B | $3.4B | ||
| Q2 25 | $6.3B | $3.4B | ||
| Q1 25 | $6.1B | $3.2B | ||
| Q4 24 | $-25.7B | $3.3B | ||
| Q3 24 | $6.0B | $3.3B | ||
| Q2 24 | $22.2B | $3.2B |
净利润ADMDVA
| Q1 26 | — | $234.2M | ||
| Q4 25 | $456.0M | $234.2M | ||
| Q3 25 | $108.0M | $150.3M | ||
| Q2 25 | $219.0M | $199.3M | ||
| Q1 25 | $295.0M | $162.9M | ||
| Q4 24 | $567.0M | $259.3M | ||
| Q3 24 | $18.0M | $214.7M | ||
| Q2 24 | $486.0M | $222.7M |
毛利率ADMDVA
| Q1 26 | — | — | ||
| Q4 25 | 20.0% | — | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 21.6% | — | ||
| Q1 25 | 19.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 6.3% | — |
营业利润率ADMDVA
| Q1 26 | — | 15.5% | ||
| Q4 25 | 7.9% | 15.5% | ||
| Q3 25 | 2.3% | 14.8% | ||
| Q2 25 | 4.4% | 15.9% | ||
| Q1 25 | 5.7% | 13.6% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | 1.8% | 16.4% | ||
| Q2 24 | 2.7% | 15.9% |
净利率ADMDVA
| Q1 26 | — | 6.5% | ||
| Q4 25 | 7.5% | 6.5% | ||
| Q3 25 | 1.7% | 4.4% | ||
| Q2 25 | 3.5% | 5.9% | ||
| Q1 25 | 4.8% | 5.1% | ||
| Q4 24 | -2.2% | 7.9% | ||
| Q3 24 | 0.3% | 6.6% | ||
| Q2 24 | 2.2% | 7.0% |
每股收益（稀释后）ADMDVA
| Q1 26 | — | $3.22 | ||
| Q4 25 | $0.95 | $3.22 | ||
| Q3 25 | $0.22 | $2.04 | ||
| Q2 25 | $0.45 | $2.58 | ||
| Q1 25 | $0.61 | $2.00 | ||
| Q4 24 | $1.21 | $3.08 | ||
| Q3 24 | $0.04 | $2.50 | ||
| Q2 24 | $0.98 | $2.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $700.7M |
| 总债务越低越好 | $7.6B | $10.2B |
| 股东权益账面价值 | $22.7B | $-651.1M |
| 总资产 | $52.4B | $17.5B |
| 负债/权益比越低杠杆越低 | 0.33× | — |
8季度趋势，按日历期对齐
现金及短期投资ADMDVA
| Q1 26 | — | $700.7M | ||
| Q4 25 | $1.0B | $700.7M | ||
| Q3 25 | $1.2B | $736.5M | ||
| Q2 25 | $1.1B | $739.4M | ||
| Q1 25 | $864.0M | $511.9M | ||
| Q4 24 | $611.0M | $846.0M | ||
| Q3 24 | $784.0M | $1.1B | ||
| Q2 24 | $764.0M | $437.2M |
总债务ADMDVA
| Q1 26 | — | $10.2B | ||
| Q4 25 | $7.6B | $10.2B | ||
| Q3 25 | — | $10.2B | ||
| Q2 25 | — | $10.1B | ||
| Q1 25 | — | $9.6B | ||
| Q4 24 | $8.3B | $9.2B | ||
| Q3 24 | $7.6B | $9.3B | ||
| Q2 24 | — | $8.5B |
股东权益ADMDVA
| Q1 26 | — | $-651.1M | ||
| Q4 25 | $22.7B | $-651.1M | ||
| Q3 25 | $22.5B | $-571.9M | ||
| Q2 25 | $22.4B | $-369.6M | ||
| Q1 25 | $22.1B | $-267.1M | ||
| Q4 24 | $22.2B | $121.1M | ||
| Q3 24 | $22.0B | $386.7M | ||
| Q2 24 | $22.2B | $632.9M |
总资产ADMDVA
| Q1 26 | — | $17.5B | ||
| Q4 25 | $52.4B | $17.5B | ||
| Q3 25 | $51.9B | $17.6B | ||
| Q2 25 | $52.0B | $17.5B | ||
| Q1 25 | $53.4B | $17.1B | ||
| Q4 24 | $53.3B | $17.3B | ||
| Q3 24 | $52.2B | $17.5B | ||
| Q2 24 | $52.7B | $17.0B |
负债/权益比ADMDVA
| Q1 26 | — | — | ||
| Q4 25 | 0.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.37× | 75.76× | ||
| Q3 24 | 0.35× | 23.95× | ||
| Q2 24 | — | 13.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-313.0M | — |
| 自由现金流经营现金流 - 资本支出 | $-669.0M | — |
| 自由现金流率自由现金流/营收 | -11.1% | — |
| 资本支出强度资本支出/营收 | 5.9% | — |
| 现金转化率经营现金流/净利润 | -0.69× | — |
| 过去12个月自由现金流最近4个季度 | $4.2B | — |
8季度趋势，按日历期对齐
经营现金流ADMDVA
| Q1 26 | — | — | ||
| Q4 25 | $-313.0M | $540.7M | ||
| Q3 25 | $1.8B | $841.5M | ||
| Q2 25 | $4.3B | $324.2M | ||
| Q1 25 | $-342.0M | $180.0M | ||
| Q4 24 | $322.0M | $547.6M | ||
| Q3 24 | $1.3B | $810.4M | ||
| Q2 24 | $468.0M | $798.8M |
自由现金流ADMDVA
| Q1 26 | — | — | ||
| Q4 25 | $-669.0M | $395.3M | ||
| Q3 25 | $1.5B | $675.4M | ||
| Q2 25 | $4.0B | $203.1M | ||
| Q1 25 | $-633.0M | $36.8M | ||
| Q4 24 | $-170.0M | $377.0M | ||
| Q3 24 | $919.0M | $671.4M | ||
| Q2 24 | $106.0M | $674.1M |
自由现金流率ADMDVA
| Q1 26 | — | — | ||
| Q4 25 | -11.1% | 10.9% | ||
| Q3 25 | 23.6% | 19.7% | ||
| Q2 25 | 63.0% | 6.0% | ||
| Q1 25 | -10.3% | 1.1% | ||
| Q4 24 | 0.7% | 11.4% | ||
| Q3 24 | 15.3% | 20.6% | ||
| Q2 24 | 0.5% | 21.2% |
资本支出强度ADMDVA
| Q1 26 | — | — | ||
| Q4 25 | 5.9% | 4.0% | ||
| Q3 25 | 4.6% | 4.9% | ||
| Q2 25 | 4.8% | 3.6% | ||
| Q1 25 | 4.7% | 4.4% | ||
| Q4 24 | -1.9% | 5.2% | ||
| Q3 24 | 6.4% | 4.3% | ||
| Q2 24 | 1.6% | 3.9% |
现金转化率ADMDVA
| Q1 26 | — | — | ||
| Q4 25 | -0.69× | 2.31× | ||
| Q3 25 | 16.75× | 5.60× | ||
| Q2 25 | 19.63× | 1.63× | ||
| Q1 25 | -1.16× | 1.10× | ||
| Q4 24 | 0.57× | 2.11× | ||
| Q3 24 | 72.22× | 3.77× | ||
| Q2 24 | 0.96× | 3.59× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADM
| Starchesandsweeteners | $1.4B | 23% |
| Ag Services | $1.1B | 18% |
| Human Nutrition | $961.0M | 16% |
| Refined Productsand Other | $924.0M | 15% |
| Animal Nutrition | $825.0M | 14% |
| Vantage Corn Processors | $700.0M | 12% |
| Transferred Over Time | $176.0M | 3% |
| Crushing | $59.0M | 1% |
DVA
暂无分部数据
